BIO-TECHNE Corp (TECH) income statement
TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 12/3051% above fair value
$72.75+0.12 (+0.17%)
Close on Nov 18, 2026Market cap $11.43BP/E 62.7Yield 0.44%
BIO-TECHNE Corp financial ratios
See a number that looks wrong?